172 related articles for article (PubMed ID: 21623205)
81. [The immunohistochemical characteristics of cervical glandular intraepithelial neoplasias].
Museridze NG; Turashvili GA; Burkadze GM
Georgian Med News; 2005 Oct; (127):77-81. PubMed ID: 16308451
[TBL] [Abstract][Full Text] [Related]
82. Desmoplastic stromal response as defined by positive α-smooth muscle actin staining is predictive of invasion in adenocarcinoma of the uterine cervix.
Jordan SM; Watanabe T; Osann K; Monk BJ; Lin F; Rutgers JK
Int J Gynecol Pathol; 2012 Jul; 31(4):369-76. PubMed ID: 22653352
[TBL] [Abstract][Full Text] [Related]
83. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material.
McCluggage WG; Maxwell P; McBride HA; Hamilton PW; Bharucha H
Int J Gynecol Pathol; 1995 Jul; 14(3):209-16. PubMed ID: 8600071
[TBL] [Abstract][Full Text] [Related]
84. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression.
Li C; Rock KL; Woda BA; Jiang Z; Fraire AE; Dresser K
Mod Pathol; 2007 Feb; 20(2):242-7. PubMed ID: 17192788
[TBL] [Abstract][Full Text] [Related]
85. The spectrum of cervical glandular neoplasia and issues in differential diagnosis.
Loureiro J; Oliva E
Arch Pathol Lab Med; 2014 Apr; 138(4):453-83. PubMed ID: 24678677
[TBL] [Abstract][Full Text] [Related]
86. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
[TBL] [Abstract][Full Text] [Related]
87. Adhesion molecules and p16 expression in endocervical adenocarcinoma.
Carico E; Fulciniti F; Giovagnoli MR; Losito NS; Botti G; Benincasa G; Farnetano MG; Vecchione A
Virchows Arch; 2009 Sep; 455(3):245-51. PubMed ID: 19680686
[TBL] [Abstract][Full Text] [Related]
88. [The detection of p16 protein in uterine cervix lesions].
Rotterová P; Nenutil R; Rotter L; Hanzelková Z; Dvoráková Z; Chovanec JZ; Kyclová J; Kren L
Ceska Gynekol; 2005 Jul; 70(4):295-8. PubMed ID: 16128131
[TBL] [Abstract][Full Text] [Related]
89. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
Shukla A; Thomas D; Roh MH
Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
[TBL] [Abstract][Full Text] [Related]
90. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
[TBL] [Abstract][Full Text] [Related]
91. [Cytological findings in glandular lesions of the uterine cervix].
Baltisser I
Pathologe; 2020 Dec; 41(Suppl 2):155-158. PubMed ID: 33113048
[TBL] [Abstract][Full Text] [Related]
92. Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Kok LF; Wang PH; Wu TS; Tyan YS; Cheng YW; Lee MY; Yang SF
Mod Pathol; 2009 Jun; 22(6):797-806. PubMed ID: 19347018
[TBL] [Abstract][Full Text] [Related]
93. The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significance.
Balan R; Căruntu ID; Amălinei C
Curr Pharm Des; 2013; 19(8):1430-8. PubMed ID: 23016776
[TBL] [Abstract][Full Text] [Related]
94. Histologic and immunohistochemical characteristics of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix.
Aoyama C; Liu P; Ostrzega N; Holschneider CH
Am J Clin Pathol; 2005 May; 123(5):699-706. PubMed ID: 15981809
[TBL] [Abstract][Full Text] [Related]
95. Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri with particular reference to adenocarcinoma in situ.
Rollason TP; Byrne P; Williams A; Brown G
J Clin Pathol; 1988 May; 41(5):547-52. PubMed ID: 3384986
[TBL] [Abstract][Full Text] [Related]
96. Differential Diagnosis between Primary Endocervical and Endometrial Adenocarcinoma using Immunohistochemical Staining of Estrogen Receptor, Vimentin, Carcinoembryonic Antigen and p16.
Yanaranop M; Ayuwat S; Nakrangsee S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S106-15. PubMed ID: 27266224
[TBL] [Abstract][Full Text] [Related]
97. BD ProEx C immunostaining in extramammary Paget's disease and perineal melanoma.
Walts AE; Bose S
Mod Pathol; 2009 Feb; 22(2):246-51. PubMed ID: 18931649
[TBL] [Abstract][Full Text] [Related]
98. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract][Full Text] [Related]
99. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions.
van Hoeven KH; Ramondetta L; Kovatich AJ; Bibbo M; Dunton CJ
Int J Gynecol Pathol; 1997 Jan; 16(1):15-21. PubMed ID: 8986527
[TBL] [Abstract][Full Text] [Related]
100. Expression of ProEx C in primary and metastatic urothelial carcinoma.
Liu L; Cohen C; Siddiqui MT
Diagn Cytopathol; 2015 Mar; 43(3):181-7. PubMed ID: 24975746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
